Fig. 1. Scheme depicting the strategy for treatment of advanced sarcoma at MSKCC. Patients are treated with repeated 3-week cycles comprised of gemcitabine (900mg/m²) on Day 1, gemcitabine (900mg/m²) + docetaxel (75mg/m²) on Day 8, and a drug holiday for the third week.